Article Information
History
- February 7, 2019.
Article Versions
- Version 1 (January 29, 2019 - 15:44).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Galen E.B. Wright1,
- Jennifer A. Collins1,
- Chris Kay1,
- Cassandra McDonald1,
- Egor Dolzhenko2,
- Qingwen Xia1,
- Kristina Bečanović1,3,
- Alicia Semaka4,
- Charlotte M. Nguyen5,6,
- Brett Trost5,
- Fiona Richards7,
- Emilia K. Bijlsma8,
- Ferdinando Squitieri9,
- Stephen W. Scherer5,6,10,
- Michael A. Eberle2,
- Ryan K.C. Yuen5,6 and
- Michael R. Hayden1,*
- 1Centre for Molecular Medicine Therapeutics, Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada
- 2Illumina Inc, San Diego, California, USA
- 3Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
- 4Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada
- 5The Hospital For Sick Children, The Centre for Applied Genomics, Genetics and Genome Biology
- 6University of Toronto, Department of Molecular Genetics
- 7Department of Clinical Genetics, Children’s Hospital at Westmead
- 8Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands
- 9Huntington and Rare Diseases Unit, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
- 10McLaughlin Centre, University of Toronto.
- ↵*Corresponding author: Michael R. Hayden (mrh{at}cmmt.ubc.ca), Tel: +1 6048753535; Fax: +1 6048753819; 950 W 28th Ave, Vancouver, BC V5Z 4H4, Canada